Literature DB >> 6402508

Utilization of exogenously added acetyl coenzyme A by intact isolated lysosomes.

L H Rome, D F Hill, K J Bame, L R Crain.   

Abstract

Acetyl coenzyme A has been shown to be required for heparan sulfate degradation for the acetylation of terminal alpha-linked glucosamine residues (Klein, U., Kresse, H., and von Figura, K. (1978) Proc. Natl. Acad. Sci. U.S.A. 75, 5185-5189). We can now demonstrate this requirement in intact isolated lysosomes. When lysosomes deficient in the enzyme alpha-N-acetylglucosaminidase were incubated at 37 degrees C with [3H]acetyl-CoA, tritium was incorporated primarily into glycosaminoglycans. By utilizing hydrolytic enzymes of known specificity, the labeled glycosaminoglycan was identified as heparan sulfate and the radioactivity was shown to be located in acetyl moieties of terminal alpha-N-acetylglucosamine residues. The acetylation of heparan sulfate in alpha-N-acetylglucosaminidase-deficient lysosomes could be stimulated by the addition of 0.5 mM ATP. Lysosomes from normal cells produced some labeled heparan sulfate; however, these organelles showed a significant incorporation of [3H]acetate into free N-acetylglucosamine that was increased over 10-fold by the addition of ATP. The N-acetylation was catalyzed by the enzyme acetyl-CoA:alpha-glucosaminide N-acetyltransferase since lysosomes deficient in this enzyme were unable to incorporate [3H]acetate into either heparan sulfate or N-acetylglucosamine even in the presence of ATP. Incorporation of [3H]acetate from [3H]acetyl-CoA into heparan sulfate (by alpha-N-acetylglucosaminidase-deficient lysosomes) and into N-acetylglucosamine (by normal lysosomes) showed a similar concentration dependence. The concentration for half-maximal incorporation of [3H]acetate was approximately 1 microM for both.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC.

Authors:  Stéphanie Durand; Matthew Feldhammer; Eric Bonneil; Pierre Thibault; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

2.  Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome).

Authors:  Martin Hrebícek; Lenka Mrázová; Volkan Seyrantepe; Stéphanie Durand; Nicole M Roslin; Lenka Nosková; Hana Hartmannová; Robert Ivánek; Alena Cízkova; Helena Poupetová; Jakub Sikora; Jana Urinovská; Viktor Stranecký; Jirí Zeman; Pierre Lepage; David Roquis; Andrei Verner; Jérome Ausseil; Clare E Beesley; Irène Maire; Ben J H M Poorthuis; Jiddeke van de Kamp; Otto P van Diggelen; Ron A Wevers; Thomas J Hudson; T Mary Fujiwara; Jacek Majewski; Kenneth Morgan; Stanislav Kmoch; Alexey V Pshezhetsky
Journal:  Am J Hum Genet       Date:  2006-09-08       Impact factor: 11.025

3.  Human acetyl-coenzyme A:alpha-glucosaminide N-acetyltransferase. Kinetic characterization and mechanistic interpretation.

Authors:  P J Meikle; A M Whittle; J J Hopwood
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

4.  Lysosomal degradation of glycoproteins and glycosaminoglycans. Efflux and recycling of sulphate and N-acetylhexosamines.

Authors:  L H Rome; D F Hill
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

5.  A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis.

Authors:  R L Pisoni; T L Acker; K M Lisowski; R M Lemons; J G Thoene
Journal:  J Cell Biol       Date:  1990-02       Impact factor: 10.539

6.  Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C.

Authors:  Alexey V Pshezhetsky
Journal:  Rare Dis       Date:  2015-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.